https://www.selleckchem.com/products/MG132.html
Kruskal-Wallis tests indicated significant differences (p0.05) between Me-EGF-containing treatment group and the other two groups in vascularity, pigmentation, elasticity, and the VSS total score, at either 6th month, 9th month, or both time points. The only parameter not showing any significant between-group difference was scar height, but the pattern still remained the same, in which Me-EGF group scored better in both month 6 and 9. Surgical incisions in lower abdomen posed challenge in scar management. Our findings suggest that Me-